Overview of Potential Clinical Applications of Hemoglobin Vesicles (HbV) as Artificial Red Cells, Evidenced by Preclinical Studies of the Academic Research Consortium
Source abstract
Abstract
Hemoglobin (Hb) is the most abundant protein in whole blood. This fact implies that the oxygen binding and releasing function of Hb is the most vital for sustaining life. All Hb is compartmentalized in red blood cells (RBCs) with corpuscular Hb concentration of about 35 g/dL, covered with a thin biomembrane. In spite of its abundance, Hb sometimes shows toxicity once it is leaked from RBCs. The shielding effect of the RBC membrane is physiologically important. Based on this structural importance, we have studied artificial red cells (Hb vesicles, HbV) as artificial oxygen carriers, which encapsulate a purified and concentrated Hb solution in phospholipid vesicles, mimicking the cellular structure of RBCs. Our academic research consortium has clarified the safety and efficacy of this HbV, aiming at clinical applications. Because of some superior characteristics to those of RBCs, HbV has the potential for use not only as a transfusion alternative but also for oxygen and carbon monoxide therapeutics, perfusate for transplant organs, and photosensitizer. In this review paper, such potential applications are summarized.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Hemoglobin structure and function · Heme Oxygenase-1 and Carbon Monoxide · Erythrocyte Function and Pathophysiology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan
Funding
Japan Society for the Promotion of Sciences · Japan Agency for Medical Research and Development
References (52)
Show source-provided references
1. Winslow, R.M. (2005). Blood Substitutes, Elsevier.
2. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: A metaanalysis10.1001/jama.299.19.jrv80007 ↗
3. Semipermeable microcapsules10.1126/science.146.3643.524 ↗
4. Negative staining of phospholipids and their structure modification by surface-active agents as observed in the electron microscope10.1016/S0022-2836(64)80115-7 ↗
5. Lipid encapsulated hemoglobin as a synthetic erythrocyte
6. Hemoglobin-vesicles as an artificial oxygen carrier10.1016/S0076-6879(09)65019-9 ↗
7. Static structures and dynamics of hemoglobin vesicle (HbV) developed as a transfusion alternative10.1021/jp9002142 ↗
8. Molecular dimensions of Hb-based O2 carriers determine constriction of resistance arteries and hypertension10.1152/ajpheart.2000.279.3.H908 ↗
9. Effect of Hb-encapsulation with vesicles on H2O2 reaction and lipid peroxidation10.1021/bc025546k ↗
10. Encapsulation of concentrated hemoglobin solution in phospholipid vesicles retards the reaction with NO, but not CO, by intracellular diffusion barrier10.1074/jbc.M707660200 ↗
11. Interaction of hemoglobin vesicles, a cellular-type artificial oxygen carrier, with human plasma: Effects on coagulation, kallikrein-kinin, and complement systems10.1080/00207450500428204 ↗
12. Effects of hemoglobin vesicles on resting and agonist-stimulated human platelets in vitro10.1081/BIO-200055856 ↗
13. Cardiopulmonary hemodynamic responses to the small injection of hemoglobin vesicles (artificial oxygen carriers) in miniature pigs10.1002/jbm.a.34208 ↗
14. Phagocytosis of liposome particles by rat splenic immature monocytes makes them transiently and highly immunosuppressive in ex vivo culture conditions10.1124/jpet.110.172510 ↗
15. Acute 40 percent exchange-transfusion with hemoglobin-vesicles (HbV) suspended in recombinant human serum albumin solution: Degradation of HbV and erythropoiesis in a rat spleen for 2 weeks10.1111/j.1537-2995.2006.00727.x ↗
16. Electrostatic interactions and complement activation on the surface of phospholipid vesicle containing acidic lipids: Effect of the structure of acidic groups10.1016/j.bbamem.2008.01.006 ↗
17. Physiological capacity of the reticuloendothelial system for the degradation of hemoglobin vesicles (artificial oxygen carriers) after massive intravenous doses by daily repeated infusions for 14 days10.1124/jpet.104.073049 ↗
18. Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model10.1016/j.biomaterials.2003.11.005 ↗
19. Pharmacokinetic study of enclosed hemoglobin and outer lipid component after the administration of hemoglobin vesicles as an artificial oxygen carrier10.1124/dmd.109.027094 ↗
20. Synthesis and physicochemical characterization of a series of hemoglobin-based oxygen carriers: Objective comparison between cellular and acellular types10.1021/bc9900789 ↗
21. Intravenous infusion of Hb-vesicles (artificial oxygen carriers) after repetitive blood exchange with a series of plasma expanders (water-soluble biopolymers) in a rat model10.1002/pat.1964 ↗
22. Surface modification of hemoglobin vesicles with poly(ethylene glycol) and affects on aggregation, viscosity, and blood flow during 90% exchange transfusion in anesthetized rats10.1021/bc960069p ↗
23. Subcutaneous microvascular responses to hemodilution with a red cell substitute consisting of polyethyleneglycol-modified vesicles encapsulating hemoglobin10.1002/(SICI)1097-4636(199804)40:1<66::AID-JBM8>3.0.CO;2-P ↗
24. Microvascular responses to hemodilution with Hb vesicles as red blood cell substitutes: Influence of O2 affinity10.1152/ajpheart.1999.276.2.H553 ↗
25. Hemoglobin-vesicles suspended in recombinant human serum albumin for resuscitation from hemorrhagic shock in anesthetized rats10.1097/01.CCM.0000109774.99665.22 ↗
26. Hemorrhagic shock resuscitation with an artificial oxygen carrier, hemoglobin vesicle, maintain intestinal perfusion and suppress the increase in plasma tumor necrosis factor-α10.1097/01.MAT.0000136508.51676.EF ↗
27. Fluid resuscitation with hemoglobin vesicles in a rabbit model of acute hemorrhagic shock10.1097/01.shk.0000192118.68295.5d ↗
28. Fluid resuscitation with artificial oxygen carriers in hemorrhaged rats: Profiles of hemoglobin vesicles degradation and hematopoiesis for 14 days10.1097/SHK.0b013e31817d4066 ↗
29. Tokuno, M., Taguchi, K., Yamasaki, K., Sakai, H., and Otagiri, M. (2016). Long-term stored hemoglobin-vesicles, a cellular type of hemoglobin-based oxygen carrier, has resuscitative effects comparable to that for fresh red blood cells in a rat model with massive hemorrhage without post-transfusion lung injury. PLoS ONE, 11.10.1371/journal.pone.0165557 ↗
30. Fluid resuscitation of hemorrhagic shock with hemoglobin vesicles in beagle dogs: Pilot study10.3109/10731199.2011.637929 ↗
31. Kim, H.W., and Greenburg, A.G. (2013). Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics, Springer.10.1007/978-3-642-40717-8 ↗
32. Effect of the cellular-type artificial oxygen carrier hemoglobin vesicle as a resuscitative fluid for prehospital treatment: Experiments in a rat uncontrolled hemorrhagic shock model10.1097/SHK.0b013e31825ad7cf ↗
33. Use of hemoglobin vesicles during cardiopulmonary bypass priming prevents neurocognitive decline in rats10.1161/CIRCULATIONAHA.105.000562 ↗
34. Effect of hemoglobin vesicle, a cellular-type artificial oxygen carrier, on middle cerebral artery occlusion- and arachidonic acid-induced stroke models in rats10.1016/j.neulet.2007.04.080 ↗
35. Hemoglobin vesicles reduce hypoxia-related inflammation in critically ischemic hamster flap tissue10.1097/01.CCM.0000257463.71761.97 ↗
36. Hemoglobin vesicles improve wound healing and tissue survival in critically ischemic skin in mice10.1152/ajpheart.00430.2009 ↗
37. Artificial oxygen carriers rescue placental hypoxia and improve fetal development in the rat pre-eclampsia model10.1038/srep15271 ↗
38. Systemic administration of hemoglobin vesicle elevates tumor tissue oxygen tension and modifies tumor response to irradiation10.1016/j.jss.2007.12.770 ↗
39. Cerebral oxygen metabolism of rats using injectable 15O-oxygen with a steady-state method10.1038/jcbfm.2011.125 ↗
40. Automatic labeling method for injectable 15O-oxygen using hemoglobin-containing liposome vesicles and its application for measurement of brain oxygen consumption by PET10.1016/j.nucmedbio.2009.08.004 ↗
41. The role of luminal factors in the recovery of gastric function and behavioral changes after chronic Helicobacter pylori infection10.1152/ajpgi.90316.2008 ↗
42. Normothermic preservation of the rat hind limb with artificial oxygen-carrying hemoglobin vesicles10.1097/TP.0000000000000528 ↗
43. Use of liposome encapsulated hemoglobin as an oxygen carrier for fetal and adult rat liver cell culture10.1016/j.jbiosc.2011.07.004 ↗
44. Photosensitizer effects of artificial red cells on dye laser irradiation in an animal model assuming port-wine stain treatment10.1097/PRS.0000000000003082 ↗
45. Naito, Y., Sakai, H., Inoue, S., and Kawaguchi, M. (2017). Hemoglobin vesicles prolong the time to circulatory collapse in rats during apnea. BMC Anesth., 17.10.1186/s12871-017-0338-y ↗
46. Carbon monoxide-releasing molecules: Characterization of biochemical and vascular activities10.1161/hh0202.104530 ↗
47. Hemorrhagic shock resuscitation with carbon monoxide saturated blood10.1016/j.resuscitation.2006.06.021 ↗
48. Hemoglobin vesicles and red blood cells as carriers of carbon monoxide prior to oxygen for resuscitation after hemorrhagic shock in a rat model10.1097/SHK.0b013e318188f83d ↗
49. Carbon monoxide-bound hemoglobin-vesicles for the treatment of bleomycin-induced pulmonary fibrosis10.1016/j.biomaterials.2014.04.049 ↗
50. Evaluation of a new type of nano-sized carbon monoxide donor on treating mice with experimentally induced colitis10.1016/j.jconrel.2016.05.016 ↗
51. Carbon monoxide-bound hemoglobin vesicles ameliorate multiorgan injuries induced by severe acute pancreatitis in mice by their anti-inflammatory and antioxidative properties10.2147/IJN.S118185 ↗
52. Safety evaluation of artificial red cells (hemoglobin-vesicles) as a transfusion alternative